Circulating leptin has saturable transport into intrathecal space in humans

European Journal of Clinical Investigation

Volumn 28, Issue 11, 1998, Pages 894-897

  Koistinen, H A ^a   Karonen, S L ^a   Iivanainen, M ^b   Koivisto, V A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Leptin; Liquor; Ob protein; Saturable; Transport

Indexed keywords

LEPTIN; SERUM ALBUMIN;

ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; BODY MASS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; FEMALE; HORMONE BLOOD LEVEL; HORMONE TRANSPORT; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADIPOSE TISSUE; ADULT; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; CARRIER PROTEINS; FEEDBACK; FEMALE; HUMANS; KINETICS; LEPTIN; MALE; MIDDLE AGED; OBESITY; PROTEINS; RECEPTORS, CELL SURFACE; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 0031796971     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00386.x     Document Type: Article

References (27)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
2. Pelleymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-3.
3. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
4. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-8.
5. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
6. Lee GH, Proenca R, Montez JM et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-5.
7. Savioz A, Charnay Y, Huguenin C, Graviou C, Greggio B, Bouras C. Expression of leptin receptor mRNA (long form splice variant) in the human cerebellum. Neuroreport 1997; 8: 3123-6.
8. Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV. Localization of leptin receptor in the human brain. Neuroendocrinology 1997; 66: 145-50.
9. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17: 305-11.
10. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 1996; 2: 589-93.
11. Caro JF, Kolaczynski JW, Nyce MR et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-61.
12. Karonen S-L, Koistinen HA, Nikkinen P, Koivisto VA. Is brain uptake of leptin in vivo saturable and reduced by fasting? Eur J Nucl Med 1998; 25: 607-12.
13. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans. Identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996; 19: 992-4.
14. Tibbling G, Link H, Öhman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977; 37: 385-90.
15. Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 1977; 37: 391-6.
16. Rönnemaa T, Karonen S-L, Rissanen A, Koskenvuo M, Koivisto VA. Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann Int Med 1997; 126: 26-31.
17. Taskinen E. Cerebrospinal fluid cells and proteins in neurological diseases with known or suspected immunoactivation of the central nervous system. Academic dissertation, University of Helsinki 1983; 126-32.
18. Saad MF, Damani S, Gingerich RL et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997; 82: 579-84.
19. Couillard C, Mauriege P, Prud'homme D et al. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 1997; 40: 1178-84.
20. Wabitsch M, Blum WF, Muche R et al. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997; 100: 808-13.
21. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women-a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol 1997; 47: 101-6.
22. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet 1996; 12: 318-20.
23. Masuzaki H, Ogawa Y, Sagawa N et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nature Med 1997; 3: 1029-33.
24. Dötsch J, Adelmann M, Englaro P et al. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J Neurol Sci 1997; 151: 185-8.
25. Lahlou N, Landais P, Deboissieu DD, Bougneres P-F. Circulating leptin in normal children and during the dynamic phase of juvenile obesity-relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism. Diabetes 1997; 46: 989-93.
26. Ahima RS, Prabakaran D, Mantzoros C, Qu D et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-2.
27. Montague CT, Farooqi IS, Whitehead JP et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-8.